Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Chloride Infusions with Oxygen for Post-Stroke Muscle Weakness
NCT00933868Phase 3Completed
- Sponsor
- Relox Medical
- Start
- Apr 2009
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium chloride in stroke, sponsored by Relox Medical. Started Apr 2009; status: completed.
02
Drugs
magnesium chloride
03
Conditions
stroke
Beyond the preview
Go deeper on NCT00933868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00933868.